4.7 Editorial Material

Dendrimer generational nomenclature: the need to harmonize

Journal

DRUG DISCOVERY TODAY
Volume 20, Issue 5, Pages 497-499

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2014.12.015

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Physical

Fabrication of thermodynamically stable self-microemulsifying drug delivery system of resveratrol with enhanced solubility and chemical stability

Sivaram Nallamolu, Vijaya Ratna Jayanti, Mallikarjun Chitneni, Liew Yun Khoon, Shikha Sood, Yassine Riadi, Prashant Kesharwani

Summary: The study successfully synthesized a highly solubilized and biocompatible formulation of RES, using SMEDDS technology to overcome issues related to poor water solubility and low bioavailability.

JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY (2022)

Review Pharmacology & Pharmacy

The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer

Sima Singh, Arshid Numan, Balaji Maddiboyina, Saahil Arora, Yassine Riadi, Shadab Md, Nabil A. Alhakamy, Prashant Kesharwani

Summary: Triple-negative breast cancers are a heterogeneous group of breast carcinomas that do not express estrogen receptor, progesterone receptor, and epidermal growth factor receptor 2. Recent trials using immune checkpoint inhibitors for treatment have shown promising early results. This review provides an overview of immunotherapy-based treatments and discusses future opportunities for their use in TNBC.

DRUG DISCOVERY TODAY (2021)

Article Pharmacology & Pharmacy

Recent update of toxicity aspects of nanoparticulate systems for drug delivery

Soma Patnaik, Bapi Gorain, Santwana Padhi, Hira Choudhury, Gamal A. Gabr, Shadab Md, Dinesh Kumar Mishra, Prashant Kesharwani

Summary: The potential of nanotechnology-based drug delivery systems has attracted the attention of researchers in recent decades, offering solutions to overcome limitations of conventional deliveries. These systems can enhance drug solubility, improve targeting potential, and ultimately maximize bioavailability and pharmacokinetics while also addressing toxicity concerns.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)

Review Environmental Sciences

Epidemiology, virology and clinical aspects of hantavirus infections: an overview

Sima Singh, Arshid Numan, Dinesh Sharma, Rahul Shukla, Amit Alexander, Gaurav Kumar Jain, Farhan Jalees Ahmad, Prashant Kesharwani

Summary: The outbreak of the COVID-19 pandemic in 2019 and 2020 has led to a new era of communicable infectious diseases, with the emergence of Hantavirus infection posing a new public health emergency. Hantavirus, a zoonotic pathogen, causes two major clinical manifestations - HFRS and HCPS. Despite the lack of effective treatments or vaccines, public awareness and precautionary measures can help reduce the spread of the virus.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH (2022)

Review Pharmacology & Pharmacy

Emerging innovations in nano-enabled therapy against age-related macular degeneration: A paradigm shift

Sunil Kumar Dubey, Rajesh Pradhan, Siddhanth Hejmady, Gautam Singhvi, Hira Choudhury, Bapi Gorain, Prashant Kesharwani

Summary: Age-related macular degeneration (AMD) is a degenerative eye disease that causes irreversible vision loss in individuals aged 50 and older, with environmental and genetic factors playing important roles. While there are currently no options to cure or treat AMD, recent innovations in nanotherapeutics offer a potential alternative for drug delivery to improve drug bioavailability and bioactivity, providing sustained release.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Pharmacology & Pharmacy

Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose

Nazeer Hasan, Mohammad Imran, Prashant Kesharwani, Kushagra Khanna, Ritu Karwasra, Nitin Sharma, Sonalika Rawat, Deeksha Sharma, Farhan Jalees Ahmad, Gaurav Kumar Jain, Aseem Bhatnagar, Sushama Talegaonkar

Summary: The study developed naloxone-loaded solid-lipid nanoparticles for intranasal administration, addressing the limitations of oral administration and achieving improved therapeutic effects; the optimized formulation showed efficient drug release and uptake by nasal membrane; in vitro and in vivo experiments demonstrated the effectiveness and safety of the nanoscale formulation in treating opioid overdose.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Review Pharmacology & Pharmacy

Evolving new-age strategies to transport therapeutics across the blood-brain-barrier

Manisha Choudhari, Siddhanth Hejmady, Ranendra Narayan Saha, Shantanu Damle, Gautam Singhvi, Amit Alexander, Prashant Kesharwani, Sunil Kumar Dubey

Summary: An understanding of the blood-brain barrier (BBB) is crucial for drug targeting to the brain, but challenges remain in treating brain diseases as traditional drugs struggle to cross the BBB.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Review Instruments & Instrumentation

Nanotechnology-based approaches applied to nutraceuticals

Akanksha R. Singh, Prasanna Kumar Desu, Ramya Krishna Nakkala, Vanitha Kondi, Sushma Devi, Mohammad Sarwar Alam, Hinna Hamid, Rajani B. Athawale, Prashant Kesharwani

Summary: Nanotechnology has opened up new possibilities in the field of nutraceuticals and food industries, offering enhanced properties and applications for nanomaterials. The small size and unique properties of nanomaterials have led to advancements in bioavailability, solubility, stability, and targeted drug delivery in the development of nano-based nutraceuticals, highlighting the potential benefits and future prospects in improving treatment strategies and quality of life in the health sectors.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Review Health Care Sciences & Services

The Promise of Nanotechnology in Personalized Medicine

Maha Ali Alghamdi, Antonino N. Fallica, Nicola Virzi, Prashant Kesharwani, Valeria Pittala, Khaled Greish

Summary: Personalized medicine and nanomedicine are both new concepts in medical practice. Personalized medicine aims to customize therapeutic management based on a patient's personal attributes, while nanomedicine applies nanotechnology advances in medicine for diagnosis and treatment. The integration of these two fields can provide more effective treatment options tailored to individual patients.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Chemistry, Analytical

Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment

Vanshikha Singh, Afsana Sheikh, Mohammed A. S. Abourehab, Prashant Kesharwani

Summary: Immunotherapy, especially the use of anti-PD-1 monoclonal antibody Dostarlimab, has shown promising results in various cancer treatments, with complete cure observed in colorectal cancer patients. This review emphasizes the mechanism of action of immunotherapy and discusses the ongoing clinical trials and combination therapies involving Dostarlimab to provide insights for future clinicians and researchers.

BIOSENSORS-BASEL (2022)

Article Chemistry, Analytical

Amelioration of Full-Thickness Wound Using Hesperidin Loaded Dendrimer-Based Hydrogel Bandages

Praveen Gupta, Afsana Sheikh, Mohammed A. S. Abourehab, Prashant Kesharwani

Summary: This study developed a dendrimer-based hydrogel bandage for the treatment of full-thickness wounds. Incorporating hesperidin, a bioflavonoid, into the dendrimer core improved its water solubility and bioavailability. The experimental results showed that the prepared formulation had better wound healing activity compared to the control group.

BIOSENSORS-BASEL (2022)

Review Medicine, General & Internal

Effect of Bariatric Surgery on Intima Media Thickness: A Systematic Review and Meta-Analysis

Tannaz Jamialahmadi, Zeljko Reiner, Mona Alidadi, Wael Almahmeed, Prashant Kesharwani, Khalid Al-Rasadi, Ali H. Eid, Manfredi Rizzo, Amirhossein Sahebkar

Summary: This meta-analysis study showed that bariatric surgery significantly reduced IMT, with the reduction remaining robust in sensitivity analysis. The study did not find a relationship between changes in IMT and changes in BMI or duration of follow-up after bariatric surgery, but subgroup analysis indicated a greater reduction in IMT after laparoscopic sleeve gastrectomy (LSG) compared to Roux-en-Y gastric bypass (RYGB).

JOURNAL OF CLINICAL MEDICINE (2022)

Review Medicine, General & Internal

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis

Tannaz Jamialahmadi, Mitra Abbasifard, Zeljko Reiner, Prashant Kesharwani, Amirhossein Sahebkar

Summary: This meta-analysis found that bariatric surgery significantly decreases MCP-1 concentration, but there was no association between the changes in BMI and absolute difference in MCP-1 levels before and after the surgery. However, a linear relationship between the changes in MCP-1 and length of follow-up was proven.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Engineering, Multidisciplinary

Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis

Prashant Kesharwani, Mahak Fatima, Vanshikha Singh, Afsana Sheikh, Waleed H. Almalki, Virendra Gajbhiye, Amirhossein Sahebkar

Summary: This study developed a new hydrogel formulation for treating onychomycosis. The sustained release of drugs from the hydrogel showed promising activity, making it an effective method of drug delivery.

BIOMIMETICS (2022)

Review Engineering, Biomedical

Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy

Amir R. Afshari, Mehdi Sanati, Prashant Kesharwani, Amirhossein Sahebkar

Summary: Standard cancer chemotherapeutics often lose effectiveness and produce adverse effects due to resistance mechanisms. Curcumin, when combined with traditional chemotherapeutics, has been found to enhance cancer treatment effectiveness and reduce resistance. However, limited bioavailability requires co-delivery strategies for Cur and conventional pharmaceuticals in clinical settings.

JOURNAL OF FUNCTIONAL BIOMATERIALS (2023)

Review Pharmacology & Pharmacy

Illuminating the druggable genome: Pathways to progress

Karlie R. Sharma, Christine M. Colvis, Griffih P. Rodgers, Douglas M. Sheeley

Summary: There are many genes within the druggable genome that have not been studied, and the US National Institutes of Health's program provides resources to explore these genes, with the potential for rapid impact on human health.

DRUG DISCOVERY TODAY (2024)

Review Pharmacology & Pharmacy

Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment

Mohammad Sameer Khan, B. H. Jaswanth Gowda, Waleed H. Almalki, Tanuja Singh, Amirhossein Sahebkar, Prashant Kesharwani

Summary: Mitochondria-specific functional liposomes hold great potential for cancer therapy. This review discusses the association between mitochondria and tumor formation, as well as the advantages of liposomes in delivering drugs to mitochondria.

DRUG DISCOVERY TODAY (2024)

Review Pharmacology & Pharmacy

Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities

Choong Yong Ung, Cristina Correia, Hu Li, Christopher M. Adams, Jennifer J. Westendorf, Shizhen Zhu

Summary: With increasing human life expectancy, the global medical burden of chronic diseases is growing. Chronic diseases often involve malfunctioning of multiple organs, and understanding the interorgan crosstalk is crucial to understanding the etiology of chronic diseases. Researchers have proposed the locked-state model (LoSM) and cutting-edge systems biology and artificial intelligence strategies to decipher chronic multiorgan locked states. The findings have important clinical implications for improving treatments for chronic diseases.

DRUG DISCOVERY TODAY (2024)